Home MarketXLS
Dashboard MarketXLS
Screener MarketXLS
Options Profit Calculator MarketXLS
Stock Ranks MarketXLS
Spreadsheet Builder MarketXLS
Documentation MarketXLS
Logout MarketXLS
Avanos Medical Inc. logo

Avanos Medical Inc.

Sector: Healthcare   

Industry: Medical Instruments & Supplies

18.71
 
USD
  
0.01
  
(0.05%)
Optionable: Yes  Market Cap: 862 M  90-day average vol: 255,739

Previous close: 18.7  Open: 18.72  Bid: 18.31  Ask: 19.75
52 week range    
17.24   
   31.31
Peers   
SKSK / 
SNDZ / 
SNN / 
Last updated: Sunday 21st April 2024
47
MarketXLS Rank
60
Value
15
Technical
68
Quality

Get Access to 1 Billion Usable Market data points IN YOUR EXCEL SHEETS WITH EASY TO USE EXCEL FUNCTIONS

Get started today
Search for a stock

🎉 Exciting news! 🎉

You are invited to join our Discord Channel.

Interact, learn, and grow with experts in the markets!

Join our Discord

Metrics

Peers

StockDividendMarket Cap (B)PEPrice ($)

SINT

0 B-1.90.5229

SKSK

SNDZ

SNN

Financials

AVNS Income Statement

Annual
Dec-14Dec-15Dec-16Dec-17Dec-18Dec-19Dec-20Dec-21Dec-22Dec-23
Amortization of intangibles-32 M-26 M-21 M-21 M-20 M801 M803 M802 M760 M796 M
Basic EPS from continuing operations-1.79-0.69-0.18-0.96-0.570.111.08-0.21
Basic EPS total0.58-9.150.851.691.22-0.96-0.570.111.08-1.32
Basic weighted shares outstanding47 M47 M47 M47 M47 M48 M48 M47 M47 M47 M
BasicDiscontinuousOperations2.642.381.4-1.11
Cost of sales-1,123 M-1,043 M-269 M-275 M-261 M295 M342 M379 M290 M294 M
Depreciation-85 M-65 M-65 M-19 M-13 M17 M24 M22 M18 M19 M
DepreciationAndAmortization-85 M-65 M-65 M-19 M-13 M17 M24 M22 M18 M19 M
Diluted EPS total0.58-9.150.851.691.22-0.96-0.570.111.07-1.32
Diluted normalized net income/share-1.79-0.69-0.18-0.96-0.570.111.07-0.21
Diluted weighted shares outstanding47 M47 M47 M47 M47 M48 M48 M47 M47 M47 M
DilutedDiscontinuousOperations2.642.381.4-1.11
GainOnSaleOfPPE6 M
GeneralAndAdministrativeExpense-17 M-22 M-22 M-24 M-20 M399 M333 M300 M327 M335 M
Gross operating profit549 M532 M297 M337 M391 M402 M373 M366 M394 M380 M
ImpairmentOfCapitalAssets474 M
Income before tax91 M-410 M-139 M-72 M-18 M-64 M-60 M7 M27 M-8 M
Income restructuring and M&A-78 M-70 M-29 M-43 M-55 M29 M30 M23 M28 M
Income taxes64 M16 M-56 M-40 M-10 M-18 M-33 M1000000.05 M2 M
Interest income3 M300000.0600000.03 M8 M7 M1 M200000.01 M3 M
InterestExpenseNonOperating6 M33 M33 M32 M26 M15 M16 M3 M10 M15 M
MiscOtherSpecialCharges-1000000.0
Net income from total operations27 M-426 M-83 M-32 M-8 M-46 M-27 M6 M51 M-62 M
NetIncomeCommonStockholders27 M-426 M-83 M-32 M-8 M-46 M-27 M6 M51 M-62 M
NetIncomeContinuousOperations27 M-426 M-83 M-32 M-8 M-46 M-27 M6 M51 M-62 M
NetIncomeDiscontinuousOperations123 M111 M98 M29 M-52 M
NetNonOperatingInterestIncomeExpense-3 M-33 M-32 M-29 M-19 M-8 M-14 M-3 M-9 M-12 M
Normalized income22 M
Operating income94 M96 M-107 M-43 M500000.0-56 M-46 M10 M36 M4 M
Operating income before depreciation (EBITDA)183 M-312 M-41 M19 M42 M-12 M-2 M49 M84 M53 M
OperatingExpense454 M435 M404 M380 M390 M458 M419 M355 M359 M376 M
Other income net-1,629 M-1,610 M-716 M-734 M10 M2 M8 M
OtherGainLossFromDispositionOfDiscontinuedOperations29 M-52 M
OtherGandA-17 M-22 M-22 M-24 M-20 M399 M333 M300 M327 M335 M
OtherImpairmentOfCapitalAssets10 M8 M8 M
OtherOperatingExpenses-4 M5 M20 M20 M8 M21 M52 M23 M3 M13 M
PromotionAndAdvertising-2 M
RentAndLandingFees-17 M-22 M-22 M-24 M-20 M
Research & development expense34 M32 M38 M38 M42 M38 M35 M32 M29 M27 M
ResearchExpense34 M32 M38 M38 M42 M38 M35 M32 M29 M27 M
RestructringAndMnAIncome-78 M-70 M-29 M-43 M-55 M29 M30 M23 M28 M
Revenue per share-32 M-26 M-21 M-21 M-20 M801 M803 M802 M760 M796 M
SalariesAndWages-14 M-15 M-13 M-10 M500000.0700000.0800000.0700000.0900000.0
Selling Gen & administrative expense425 M399 M346 M322 M340 M399 M333 M300 M327 M335 M
SellingAndMarketingExpense425 M399 M346 M322 M340 M
SellingExpense425 M399 M346 M322 M340 M
Special income/charges79 M-474 M29 M43 M55 M-29 M-30 M-23 M-28 M
Total Income available for interest expense (EBIT)97 M-377 M-106 M-41 M8 M-49 M-45 M11 M37 M7 M
Total common shares outstanding47 M47 M47 M47 M47 M48 M48 M47 M47 M46 M
Total net income27 M-426 M-83 M-32 M-8 M-46 M-27 M6 M51 M-62 M
Total ordinary shares46 M46 M46 M46 M46 M46 M46 M46 M46 M46 M
Total revenues1,672 M1,574 M566 M612 M652 M698 M715 M745 M684 M673 M
TotalExpenses-669 M-607 M135 M105 M129 M753 M761 M734 M649 M669 M
TotalRevenue1,672 M1,574 M566 M612 M652 M698 M715 M745 M684 M673 M
Call: 1-877-778-8358
Ankur Mohan MarketXLS
Welcome! I'm Ankur, the founder and CEO of MarketXLS. With more than ten years of experience, I have assisted over 2,500 customers in developing personalized investment research strategies and monitoring systems using Excel.

I invite you to book a demo with me or my team to save time, enhance your investment research, and streamline your workflows.
Implement “your own” investment strategies in Excel with thousands of MarketXLS functions and templates.

MarketXLS is a complete Excel stock solution

Kevin Hsu

StockKevin.com

I have used lots of stock and option information services. This is the only one which gives me what I need inside Excel

Lloyd Lenase

Option Day Trader

MarketXLS is a data junkie’s dream. It gives me the flexibility to mine for hidden treasures.

Dave

Swing trader since 2011

I like to access historical closing prices on a particular date. That makes tracking performance easy.

Patrick Cusatis, Ph.D., CFA

Associate Professor of Finance - Penn State University